SCHWINK LOTHAR,BUNING CHRISTIAN,GLOMBIK HEINER,GOSSEL MATTHIAS,KADEREIT DIETER,HALLAND NIS,LOHMANN MATTHIAS,PÖVERLEIN CHRISTOPH,RITTER KURT
申请号：
IN201637027913
公开号：
IN201637027913A
申请日:
2016.08.16
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
The present invention relates to substituted fused heterocyclic compounds. The substituted fused heterocyclic compounds are GPR1 19 modulators and useful for the prevention and/or treatment of diabetes obesity dyslipidemia and related disorders. The invention furthermore relates to the use of substituted fused heterocyclic compounds as active ingredients in pharmaceuticals and pharmaceutical compositions comprising them.
